Updated:
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001808865, and its reported...
Overview
iTeos Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001808865, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-03-05, it reported annual revenue of USD 35,000,000; net income of USD -134,414,000; total assets of USD 686,976,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- iTeos Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Watertown, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001808865
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2024USD | $35.0M | -$134.4M | $687.0M | $142.1M | -$98.2M | |
| FY2023USD | $12.6M | -$112.6M | $667.6M | $251.2M | -$103.8M | |
| FY2022USD | $267.6M | $96.7M | $755.0M | $284.8M | -$111.2M | |
| FY2021USD | $344.8M | $214.5M | $884.7M | $848.5M | $513.1M |
FY2022. Net income: shown as originally filed; later filings report different values for the same periods.
FY2021. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13G | — | SCHEDULE 13G |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research iTeos Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.